FDARecall 100046Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
FDA classification: Class II. Use may cause temporary or medically reversible health consequences, or the chance of serious consequences is remote. Status: Ongoing.
Is it yours? Products and codes
Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. The code is also added to the page address (?lot=…), so a copied link or result carries it.
General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
- Lot or code
- Lot #: 3047, Exp Date July 2027.
- FDA recall number
- D-0076-2027
- Quantity
- 2136 bottles
Distribution (FDA): Nationwide within the United States
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Hikma Pharmaceuticals USA INC.
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.